By www.reliablemarketforecast.com
Global Sustained Release Injectables Market Research Report 2024 Story
109
$ 2900
Sustained Release Injectables Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
AntriaBio Ascendis Pharma AstraZeneca Aurobindo Avadel Alkermes Amylin Pharmaceuticals Biomarin Camurus Critical Pharmaceuticals Durect Eli Lilly Enzon Ipsen InnoCore Pharmaceuticals Janssen Merck NanOlogy Novartis Oakwood Laboratories/PharmaSophia OctoPlus Pacira PhaseBio Pharmaceuticals Recipharm AB Roche Sanofi Taiwan Liposome Company (TLC) Xbrane Biopharma Livzon Pharm Luye Pharma Group